The Magazine for Sleep Professionals
Saturday, September 26, 2026
The thought of histamines might conjure up images of itchy hives or the tickling sensation just before a sneeze, but scientists have come to realize there is much more to histamines than their connection to allergies. Recent research reveals that histamines play a vital role in wakefulness. Produced by brain […]
Sleep apnea and insomnia are two of the most prevalent sleep disorders, often coexisting and compounding the burden on patients’ quality of life. For sleep professionals, the challenge lies in unraveling the intertwined pathology of these conditions to provide effective treatment. Given this complex interplay, it is crucial to identify […]
Panthera Dental, a global leader in CAD/CAM implant solutions and dental sleep medical devices, proudly announces the launch of its best-in-class BioMatch System, set to streamline the field of oral appliance therapy (OAT). The BioMatch System is designed to make ordering of a patient-matched appliance an effortless process, ease dental […]
A pediatric sleep specialist at Seattle Children’s Hospital, Lourdes DelRosso, MD, PhD, had long noted that many parents would come to a consultation with concerns that their children “moved a lot in their sleep, were tired during the day, or had problems in school.” The parents attributed the daytime symptoms […]
Since its inception in 2008, Wake Up Narcolepsy (WUN) has donated over $1.39 million to narcolepsy research. We are a nonprofit organization committed to advancing narcolepsy awareness, education, and research. A large part of our mission involves raising and allocating funding to develop improved treatments and ultimately, find a cure. […]
Eli Lilly and Company announced the U.S. Food and Drug Administration (FDA) approved Zepbound® (tirzepatide) as the first and only prescription medicine for adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity.1 Zepbound may help adults with moderate-to-severe obstructive sleep apnea and obesity improve their sleep disorder. It should be used with […]
Similar to its prevalence in the adult population, obstructive sleep apnea (OSA) in children is one of the most common manifestations of sleep-related breathing disorders. The prevalence of OSA in children has significantly increased in the last 20 years, particularly among the younger population, possibly linked to the rise in […]
A new clinical practice guideline developed by the American Academy of Sleep Medicine provides updated recommendations for the treatment of restless legs syndrome. The guideline reflects the latest scientific evidence and recommends significant changes in the standard treatment of RLS in adults. Available online as an accepted paper in the […]
Fisher & Paykel Healthcare has announced the launch of F&P Nova MicroTM nasal pillows mask for the treatment of obstructive sleep apnea (OSA) in the USA. Weighing less than 1.4 ounces (40 grams), the new compact mask features minimal, easy-adjusting headgear and a soft MicroPillowsTM cushion that nestles gently within […]
Avadel Pharmaceuticals plc, a biopharmaceutical company focused on transforming medicines to transform lives, announced that the U.S. District Court for the District of Columbia (“Court”) ruled in favor of the Food and Drug Administration (“FDA”) in a suit brought by Jazz Pharmaceuticals Inc. (“Jazz”) under the Administrative Procedure Act regarding […]
